Which of the following is NOT a key component of discharge planning to prevent recurrent cardiovascular events?

Prepare for the ECCO Caring for Patients with Cardiovascular Disorders Part 1 Test. Utilize flashcards and multiple-choice questions, complemented by hints and explanations for each query. Gear up for success in your exam!

Multiple Choice

Which of the following is NOT a key component of discharge planning to prevent recurrent cardiovascular events?

Explanation:
Discharge planning to prevent recurrent cardiovascular events centers on keeping patients engaged in care and actively managing therapy and risk factors after hospitalization. The aspect that does not fit this approach is limiting follow-up to six months. Regular, timely follow-up is essential to monitor how well medications are working, check for side effects, and adjust treatment as needed, which helps prevent another event. Medication adherence is a foundational piece because the protective effects of antiplatelet therapy, statins, blood pressure meds, and other prescribed drugs depend on taking them consistently. When patients take their meds as prescribed, the risk of recurrent events decreases. Risk-factor modification is equally important. This includes controlling blood pressure, managing cholesterol and blood glucose, maintaining a healthy weight, and encouraging physical activity and a heart-healthy diet. Addressing these factors lowers the overall burden of atherosclerotic disease and reduces the chance of another event. Smoking cessation is a critical part of secondary prevention. Quitting smoking substantially lowers cardiovascular risk and improves outcomes, supported by counseling and, when appropriate, approved pharmacotherapy. So, the component that does not align with effective discharge planning is delaying follow-up to six months; proactive, earlier follow-up supports ongoing optimization of therapy and risk-factor management to prevent recurrence.

Discharge planning to prevent recurrent cardiovascular events centers on keeping patients engaged in care and actively managing therapy and risk factors after hospitalization. The aspect that does not fit this approach is limiting follow-up to six months. Regular, timely follow-up is essential to monitor how well medications are working, check for side effects, and adjust treatment as needed, which helps prevent another event.

Medication adherence is a foundational piece because the protective effects of antiplatelet therapy, statins, blood pressure meds, and other prescribed drugs depend on taking them consistently. When patients take their meds as prescribed, the risk of recurrent events decreases.

Risk-factor modification is equally important. This includes controlling blood pressure, managing cholesterol and blood glucose, maintaining a healthy weight, and encouraging physical activity and a heart-healthy diet. Addressing these factors lowers the overall burden of atherosclerotic disease and reduces the chance of another event.

Smoking cessation is a critical part of secondary prevention. Quitting smoking substantially lowers cardiovascular risk and improves outcomes, supported by counseling and, when appropriate, approved pharmacotherapy.

So, the component that does not align with effective discharge planning is delaying follow-up to six months; proactive, earlier follow-up supports ongoing optimization of therapy and risk-factor management to prevent recurrence.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy